Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/26/2008


Conference Call and Webcast to Be Held Today at 5:00 p.m. ET (22:00 CET)

2007 Financial Highlights

- Total BioMarin revenue of $121.6 million

- Naglazyme net product revenue of $86.2 million, an increase of 85.4

percent over 2006 and above BioMarin's guidance range of $82 million

to $84 million

- Aldurazyme net product revenue of $123.7 million, an increase of 28.5

percent over 2006 and toward the upper end of BioMarin's guidance

range of $115 million to $125 million

- Net loss of $15.8 million, within the guidance range of a loss of $13

million to $18 million

- Net income of $2.6 million in the fourth quarter of 2007

2008 Financial Guidance

- Total BioMarin revenue in the range of $255 million to $306 million

which includes total product revenue of $213 million to $264 million

- Naglazyme net product revenue in the range of $105 million to $116

million

- Aldurazyme net product sales by Genzyme of $135 million to $145

million with net revenue to BioMarin from royalties and transfers of

inventory in the range of $68 million to $78 million

- Improved Kuvan net product revenue guidance in the range of $40

million to $70 million

- GAAP net income in the range of $20 million to $40 million and

non-GAAP net income in the range of $47 million to $67 million

NOVATO, Calif., Feb. 26 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) today announced financial results for the fourth quarter and full year ended December 31, 2007. Net income was $2.6 million ($0.03 per share) for the fourth quarter of 2007, compared to a net loss of $10.4 million ($0.11 per share) for the fourth quarter of 2006. Net income for the fourth quarter of 2007 includes the receipt of the $15.0 million milestone payment from Merck Serono related to
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
2. BioMarin to Present at the BioCentury NewsMakers Conference
3. BioMarin to Present at the Rodman & Renshaw 9th Annual Healthcare Conference
4. BioMarin and IGAN Biosciences to Collaborate on Development of an Enzyme Therapy to Treat IgA Nephropathy, a Rare and Life-Threatening Kidney Disease
5. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
6. BioMarin Appoints Dr. Gordon Vehar, Vice President of Research
7. BioMarin to Present at the Merrill Lynch 2008 Global Healthcare Conference
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... , Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ... today announced next steps for its Oral Amphotericin ... from its in vitro work involving ... iCo now plans to complete pre clinical studies ... initial Phase 1A clinical trial, utilizing approximately $700,000 ...
(Date:10/22/2014)... 22, 2014 Research and Markets  has ... by Material, by Application, Geography - Global Analysis and ... Organic electronics, also called as polymer ... science which deals with small conductive molecules and electrically ... molecules and polymers are carbon based, made using synthetic ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... 2014 Convey Computer , the ... from Iowa State University won first place in the ... Convey HC-2ex, the team’s solution achieved the highest overall ... the second place finisher. , Experts from all segments ... month long challenge, using a variety of design tools, ...
Breaking Biology Technology:iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3
... Blood ... Expertise, PALO ALTO, Calif., May 29 Pelikan Technologies ... announced the appointment of Dennert (Denny) Ware to its,board of ... of Kinetic Concepts, Inc. (KCI), a global medical,technology company, Mr. ...
... China, May 29 /Xinhua-PRNewswire-FirstCall/ -- China,Biologic Products, Inc. ... of the leading plasma-based pharmaceutical companies in the,People,s ... announced that the,Company has been approved by the ... commence the production of Human Albumin 12.5g/vial (25%,50 ...
... Clarient, Inc.,(Nasdaq: CLRT ), a premier ... oncologists and the pharmaceutical industry,today announced that, effective ... will join Clarient as Senior Vice President and ... years experience as a public,company CFO in life ...
Cached Biology Technology:Pelikan Technologies Appoints Denny Ware to Board of Directors 2Pelikan Technologies Appoints Denny Ware to Board of Directors 3China Biologic Products Announces SFDA Approval for the Production and Sale of Human Albumin 12.5g/vial (25%, 50 ml) 2China Biologic Products Announces SFDA Approval for the Production and Sale of Human Albumin 12.5g/vial (25%, 50 ml) 3Clarient Names Raymond J. Land Senior Vice President and Chief Financial Officer 2Clarient Names Raymond J. Land Senior Vice President and Chief Financial Officer 3Clarient Names Raymond J. Land Senior Vice President and Chief Financial Officer 4Clarient Names Raymond J. Land Senior Vice President and Chief Financial Officer 5
(Date:10/18/2014)... for evaluation of suspected genetic conditions, whole-exome sequencing ... including detection of a number of rare genetic ... to a study appearing in JAMA . ... the American Society of Human Genetics annual meeting. ... regions of thousands of genes simultaneously using next-generation ...
(Date:10/17/2014)... have shown for the first time how bacteria can ... giving them the opportunity to get tremendous insights into ... study also discovered the bacterial growth in chronic lung ... slowed down by the immune cells. The researchers discovered ... "suffocate" the bacteria, forcing the bacteria to switch to ...
(Date:10/16/2014)... synthesis of recent research findings to inform their management ... states. , The Ecology and Management of Moist ... of the Relevant Biophysical Science and Implications for Future ... U.S. Forest Service,s Pacific Northwest Research Station, is a ... synthesis of the large body of scientific information on ...
Breaking Biology News(10 mins):Whole-exome sequencing shows potential as diagnostic tool 2Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2New report synthesizes best available science on management of moist mixed-conifer forests 2
... RIVERSIDE, Calif. Four researchers at the University of California, ... the Advancement of Science ( AAAS ). Including this year,s ... have been recognized with AAAS Fellow distinction is 194. ... members by their peers. This year AAAS gave this honor ...
... In reaction to what midwives view as the overly ... rituals to send the message that women,s bodies know ... send the message that home birth is about female ... participatory experiences that put mothers in control, with the ...
... available in German . Chicago/Leipzig. Large forest ... Based on models, scientists can now show that there are ... Large areas of Canada are apparently approaching this threshold value ... As a result both the area burnt down annually and ...
Cached Biology News:4 UC Riverside researchers receive national recognition 2Midwives use rituals to send message that women's bodies know best 2Midwives use rituals to send message that women's bodies know best 3Rapid rise in wildfires in large parts of Canada? 2Rapid rise in wildfires in large parts of Canada? 3
... The CultureWell cell culture systems provide ... cells for staining and imaging. Each ... with standard optical-quality coverslips in cell ... provided sterile and ready to use. ...
Request Info...
Request Info...
... ml of DETACHaBEAD 19 polyclonal anti-Fab ... (Pan B). B cells isolated ... released with DETACHaBEAD CD19 are viable ... for applications such as culturing studies ...
Biology Products: